Lv641
3160 积分 2021-07-02 加入
Novel Clinical Biomarkers for Drug-Induced Liver Injury
5天前
已完结
Advances in antituberculosis drug-induced liver injury: Molecular mechanisms, genetic insights, and emerging animal-free prediction models
6天前
已完结
PBPK-PD model for predicting pharmacokinetics, tumor growth inhibition, and toxicity risks of topoisomerase inhibitor ADCs in mice and humans
1个月前
已完结
Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteins
1个月前
已完结
Opportunities and Challenges for PBPK Model of mAbs in Paediatrics and Pregnancy
1个月前
已完结
Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
1个月前
已完结
Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities
1个月前
已完结
Informing Development of Bispecific Antibodies Using Physiologically Based Pharmacokinetic‐Pharmacodynamic Models: Current Capabilities and Future Opportunities
1个月前
已完结
Exacerbation risk in patients with bronchiectasis receiving DPP-1 inhibitors vs placebo: A meta-analysis of RCTs
2个月前
已完结
The therapeutic potentials of apelin in obesity-associated diseases
3个月前
已完结
皖公网安备34019202002308
